| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Advances in Brief |
Departments of Clinical Cancer Prevention [X-C. X., S. M. L.] and Thoracic/Head & Neck Medical Oncology [W. Y. L. W., R. L.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030; Departments of Dermatology [L. G., J. E. W.] and Dermatopathology [S. C. B.], Baylor College of Medicine, Houston, Texas 77030; Austin, Texas 78745 [W. M. R.]; and Arizona Cancer Center, University of Arizona Health Sciences Center, Tucson, Arizona 85724 [D. S. A.]
Retinoids are essential for normal skin growth, differentiation, and apoptosis and are active pharmacologically in the prevention and treatment of skin cancers and other lesions. Retinoid effects are mediated mainly by retinoic acid receptors (RARs) and retinoid X receptors (RXRs), which act as transcription factors to alter gene expression. Using in situ hybridization, we analyzed the expression of RARs and RXRs in normal sun-exposed skin (n = 85), squamous cell carcinoma (SCC; n = 28), and actinic keratosis [AK (a precursor to SCC); n = 38]. The expressions of five receptors (RAR-
and -
and RXR-, -ß, and -) were moderate to very strong in normal skin, with higher expressions in spinous and granular layers than in the basal layer. RAR-ß expression was weak or absent in normal and lesion samples. All five receptors expressed in the skin were suppressed progressively from normal skin to premalignant skin (AK) to invasive skin SCC. Specific receptor decreases in lesions relative to normal skin ranged from 75% (RXR-ß) to 96% (RAR-) in SCC and from 37% (RAR-) to 68% (RXR-ß) in AK. The degree of suppression of RXR- and RAR-, the two predominant retinoid receptors in skin, was relatively less for RXR- (58% versus 86%; P = 0.015) and relatively greater for RAR- (37% versus 89%; P = 0.0001) between AK and SCC, suggesting that suppression of RXR- may be an earlier event and expression of RAR- may be a later event of multistep squamous skin carcinogenesis. Our results indicate that suppressed expression of retinoid receptors occurs early (in AK) and is associated with progression of squamous skin carcinogenesis to SCC.
This article has been cited by other articles:
|
|
 |
|
  P.-L. So, M. A. Fujimoto, and E. H. Epstein Jr. Pharmacologic retinoid signaling and physiologic retinoic acid receptor signaling inhibit basal cell carcinoma tumorigenesis Mol. Cancer Ther., May 1, 2008; 7(5): 1275 - 1284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. B. Janakiram, I. Cooma, A. Mohammed, V. E. Steele, and C. V. Rao -Ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-{alpha} in human colon cancer cells Mol. Cancer Ther., January 1, 2008; 7(1): 181 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Chakravarti, R. Lotan, A. H. Diwan, C. L. Warneke, M. M. Johnson, and V. G. Prieto Decreased Expression of Retinoid Receptors in Melanoma: Entailment in Tumorigenesis and Prognosis Clin. Cancer Res., August 15, 2007; 13(16): 4817 - 4824. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Mirza, M. Fishman, I. Fricke, M. Dunn, A. M. Neuger, T. J. Frost, R. M. Lush, S. Antonia, and D. I. Gabrilovich All-trans-Retinoic Acid Improves Differentiation of Myeloid Cells and Immune Response in Cancer Patients. Cancer Res., September 15, 2006; 66(18): 9299 - 9307. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Rebel, N. Kram, A. Westerman, S. Banus, H. J. van Kranen, and F. R. de Gruijl Relationship between UV-induced mutant p53 patches and skin tumours, analysed by mutation spectra and by induction kinetics in various DNA-repair-deficient mice Carcinogenesis, December 1, 2005; 26(12): 2123 - 2130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.-L. So, K. Lee, J. Hebert, P. Walker, Y. Lu, J. Hwang, L. Kopelovich, M. Athar, D. Bickers, M. Aszterbaum, et al. Topical Tazarotene Chemoprevention Reduces Basal Cell Carcinoma Number and Size in Ptch1+/- Mice Exposed to Ultraviolet or Ionizing Radiation Cancer Res., July 1, 2004; 64(13): 4385 - 4389. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Alberts, J. Ranger-Moore, J. Einspahr, K. Saboda, P. Bozzo, Y. Liu, X.-c. Xu, R. Lotan, J. Warneke, S. Salasche, et al. Safety and Efficacy of Dose-Intensive Oral Vitamin A in Subjects with Sun-Damaged Skin Clin. Cancer Res., March 15, 2004; 10(6): 1875 - 1880. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Hansen, D. Brown, V. Virador, T. Tanaka, F. Andreola, K. Strain, B. Dancheck, R. Riley, J. M. Arbeit, L. M. De Luca, et al. A PMLRARA Transgene Results in a Retinoid-deficient Phenotype Associated with Enhanced Susceptibility to Skin Tumorigenesis Cancer Res., September 1, 2003; 63(17): 5257 - 5265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-Y. Fan, T. E. Spencer, N. Wang, M. P. Moyer, and R. S. Chapkin Chemopreventive n-3 fatty acids activate RXR{alpha} in colonocytes Carcinogenesis, September 1, 2003; 24(9): 1541 - 1548. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kusmartsev, F. Cheng, B. Yu, Y. Nefedova, E. Sotomayor, R. Lush, and D. Gabrilovich All-trans-Retinoic Acid Eliminates Immature Myeloid Cells from Tumor-bearing Mice and Improves the Effect of Vaccination Cancer Res., August 1, 2003; 63(15): 4441 - 4449. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. M. Blokx, J. V. Smit, P. C. M. de Wilde, P. C. M. van de Kerkhof, D. J. Ruiter, and E. M. G. J. de Jong Immunohistochemical Effects of Temporary Cessation of Long-term Acitretin Treatment in Keratinocytic Intraepidermal Neoplasia of Renal Transplant Recipients Arch Dermatol, May 1, 2003; 139(5): 671 - 673. [Full Text] [PDF]
|
|
|
|
|
|
J. Huang, W. C. Powell, A. C. Khodavirdi, J. Wu, T. Makita, R. D. Cardiff, M. B. Cohen, H. M. Sucov, and P. Roy-Burman Prostatic Intraepithelial Neoplasia in Mice with Conditional Disruption of the Retinoid X Receptor{alpha} Allele in the Prostate Epithelium Cancer Res., August 15, 2002; 62(16): 4812 - 4819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Clifford, E. Walch, X. Yang, X. Xu, D. S. Alberts, G. L. Clayman, A. K. El-Naggar, R. Lotan, and S. M. Lippman Suppression of Type I Interferon Signaling Proteins Is an Early Event in Squamous Skin Carcinogenesis Clin. Cancer Res., July 1, 2002; 8(7): 2067 - 2072. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E.W. Cohen and E. E. Vokes Searching for a Standard J. Clin. Oncol., January 15, 2002; 20(2): 359 - 361. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Shin, B. S. Glisson, F. R. Khuri, J. L. Clifford, G. Clayman, S. E. Benner, A. A. Forastiere, L. Ginsberg, D. Liu, J. J. Lee, et al. Phase II and Biologic Study of Interferon Alfa, Retinoic Acid, and Cisplatin in Advanced Squamous Skin Cancer J. Clin. Oncol., January 15, 2002; 20(2): 364 - 370. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hatoum, M. E. El-Sabban, J. Khoury, S. H. Yuspa, and N. Darwiche Overexpression of retinoic acid receptors alpha and gamma into neoplastic epidermal cells causes retinoic acid-induced growth arrest and apoptosis Carcinogenesis, December 1, 2001; 22(12): 1955 - 1963. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
